We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

021240:KRXCoway Co., Ltd. Analysis

Data as of 2026-03-14 - not real-time

₩73,600.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Current price (≈73,600 KRW) sits well below the 20‑day, 50‑day and 200‑day moving averages, with an RSI around 36 suggesting the stock is edging toward oversold territory. The MACD remains in a bearish configuration, yet trading volume is on the rise, indicating renewed interest. A discounted cash‑flow model places fair value near 110,000 KRW, implying roughly 59% upside, while the forward P/E of about 7× and a dividend yield of 2.6% (payout ~33%) add value appeal.
Fundamentally, Coway delivered 14% revenue growth YoY, maintains a robust gross margin above 60% and an operating margin near 20%. Return on equity sits at 17.7%, and free cash flow is healthy, supporting the dividend and offsetting a debt‑to‑equity ratio around 63%. Analysts (11) rate the stock as a strong‑buy with a median target of 115,000 KRW, underscoring the perceived undervaluation.
Risk considerations include elevated 30‑day volatility (≈51%) but a low beta (~0.34), tempering market‑wide swings. The consumer‑cyclical sector poses moderate cyclical risk, while regulatory and geographic exposures are assessed as medium. Liquidity appears comfortable given increasing volume and a large market cap, leading to a balanced risk‑adjusted outlook.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Significant DCF upside potential
  • Attractive dividend yield with sustainable payout
  • Increasing trading volume indicating renewed interest

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue and margin growth
  • Analyst consensus strong‑buy and high target prices
  • Low beta reducing market‑wide volatility exposure

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Robust cash‑flow generation supporting dividend sustainability
  • Undervaluation relative to fair‑value estimate
  • Stable financial profile with solid ROE and manageable leverage

Key Metrics & Analysis

Financial Health

Revenue Growth14.00%
Profit Margin11.94%
P/E Ratio7.1
ROE17.68%
ROA9.06%
Debt/Equity62.95
Op. Cash Flow₩48.7B
Free Cash Flow₩395.8B

Technical Analysis

TrendNeutral
RSI36.0
Support₩68,800.00
Resistance₩90,500.00
MA 20₩80,975.00
MA 50₩80,886.00
MA 200₩92,825.50
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair Value₩109,892.88
Target Price₩117,090.91
Upside/Downside59.09%
GradeUndervalued
TypeBlend
Dividend Yield2.64%

Risk Assessment

Beta0.34
Volatility51.10%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.